Stifel Financial
TGTX icon

Stifel Financial’s TG Therapeutics TGTX Stock Holding History

Stifel Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.92M Buy
52,298
+2,633
+5% +$142K ﹤0.01% 1781
2026
Q2 		$2.73M Buy
49,665
+4,523
+10% +$185K ﹤0.01% 1846
2026
Q1 		$1.5M Buy
45,142
+7,673
+20% +$229K ﹤0.01% 2157
2025
Q4 		$1.12M Buy
37,469
+25,349
+209% +$828K ﹤0.01% 2359
2025
Q3 		$438K Sell
12,120
-5,395
-31% -$178K ﹤0.01% 2894
2025
Q2 		$630K Buy
+17,515
New +$652K ﹤0.01% 2626
2019
Q2 		– Sell
-14,420
Closed -$116K – 3044
2019
Q1 		$116K Hold
14,420
– – ﹤0.01% 2684
2018
Q4 		$59K Buy
+14,420
New +$71.7K ﹤0.01% 2601

Other funds holding TGTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 20.64% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Stifel Financial's TGTX Position: Q3 2026 in Review

Stifel Financial increased its TG Therapeutics (TGTX) stake by 5.3% in Q3 2026, buying an estimated $142K and bringing the position to 52,298 shares worth $2.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Stifel Financial first reported a position in TGTX in Q4 2018 and has held it in 8 quarters since. 361 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Stifel Financial held 52,298 shares of TG Therapeutics worth $2.92M as of Q3 2026.
  • Stifel Financial bought 2,633 TG Therapeutics shares in Q3 2026, an estimated $142K.
  • TG Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #1781 holding.
  • Stifel Financial first reported a position in TG Therapeutics in Q4 2018 and has held it in 8 quarters since.
  • 361 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.